SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vip who wrote (118)6/3/1997 2:03:00 PM
From: Peter H. Proctor   of 670
 
Agree about Iamin (TM), their wound-healing agent. OTOH, I suspect that Procyte is marketing a spray version of Graftcyte (TM) with the knowledge that there will be "off-label" use, i.e., for hair loss in general. They are not about to tell anyone this, for obvious reasons. Short -circuits the $50-100 mil that might be required to get FDA-approval for this indication. Not to mention the 5-10 years.

This is an area where no agent used alone works all that well, so combination treatment seems to be the rule. After a bit of experience, the transplant docs may start recommending spray Graftcyte for hair loss in general, perhaps along with minoxidil and/or an antiandrogen.

Dr. P
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext